Pleiotropic effects of amitriptyline ameliorate renal fibrosis

Kidney International

Volumn 75, Issue 6, 2009, Pages 583-584

  Morrissey, Jeremiah J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SCLEROPROTEIN; SPHINGOMYELIN PHOSPHODIESTERASE; TRICYCLIC ANTIDEPRESSANT AGENT;

CELL DIFFERENTIATION; CELL PROLIFERATION; COMPETITIVE INHIBITION; DISEASE COURSE; DRUG EFFECT; INFLAMMATION; KIDNEY FIBROSIS; MACROPHAGE; MONOCYTE; MYOFIBROBLAST; NONHUMAN; NOTE; PLEIOTROPY; PRIORITY JOURNAL; URETER OBSTRUCTION; WHOLE BODY RADIATION; X IRRADIATION;

EID: 61349156116     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.655     Document Type: Note

References (12)

1. Achar E, Achar RA, Paiva TB et al. Amitriptyline eliminates calculi through urinary tract smooth muscle relaxation. Kidney Int 2003; 64: 1356-1364.
2. Achar E, Maciel TT, Collares CF et al. Amitriptyline attenuates interstitial inflammation and ameliorates the progression of renal fibrosis. Kidney Int 2009; 75: 596-604.
3. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002; 283: F861-F875.
4. Misseri R, Meldrum KK. Mediators of fibrosis and apoptosis in obstructive uropathies. Curr Urol Rep 2005; 6: 140-145.
5. Bascands J-L, Schanstra JP. Obstructive nephropathy: insights from genetically engineered animals. Kidney Int 2005; 68: 925-937.
6. Chevalier RL. Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat Clin Pract Nephrol 2006; 2: 157-168.
7. Cochrane AL, Kett MM, Samuel SC et al. Renal structural and functional repair in a mouse model of reversal of ureteral obstruction. J Am Soc Nephrol 2005; 16: 3623-3630.
8. Tapmeier TT, Brown KL, Tang Z et al. Reimplantation of the ureter after unilateral ureteral obstruction provides a model that allows functional evaluation. Kidney Int 2008; 73: 885-889.
9. Hurwitz R, Ferlinz K, Sandhoff K. The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. Biol Chem Hoppe Seyler 1994; 375: 447-450.
10. Teichgraber V, Ulrich M, Endlich N et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 2008; 14: 382-391.
11. Lang PA, Schenck M, Nicolay JP et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007; 13: 164-170.
12. Rebillard A, Rioux-Leclercq N, Muller C et al. Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage. Oncogene 2008; 27: 6590-6595.